Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease

Alzheimer's and Dementia

Volumn 11, Issue 9, 2015, Pages 1041-1049

  Dubois, Bruno ^a,b,c,n   Chupin, Marie ^b   Hampel, Harald ^a,b,c   Lista, Simone ^a,b   Cavedo, Enrica ^a,b   Croisile, Bernard ^d   Louis Tisserand, Guy ^d   Touchon, Jacques ^e   Bonafe, Alain ^e   Ousset, Pierre Jean ^f,n   Ait Ameur, Amir ^g,n   Rouaud, Olivier ^h   Ricolfi, Fréderic ^h   Vighetto, Alain ^d,n   Pasquier, Florence ^i,n   Delmaire, Christine ^j,n   Ceccaldi, Mathieu ^k,n   Girard, Nadine ^k,n   Dufouil, Carole ^l   Lehericy, Stéphane ^a,b,c,n   Tonelli, Isabelle ^m   Duveau, Françoise ^m   Colliot, Olivier ^b   Garnero, Line ^b   Sarazin, Marie ^a,b,c   Dormont, Didier ^a,b,c,n   Deramond, H ⁿ   Etcharry Bouyx, F ⁿ   Pasco Papon, A ⁿ   Moreaud, O ⁿ   Krainik, A ⁿ   Bombois, S ⁿ   Couratier, P ⁿ   Maubon, A ⁿ   Croisile, B ⁿ   Louis Tisserand, G ⁿ   Michel, B ⁿ   Peretti, M P ⁿ   Benetos, A ⁿ   Barroche, G ⁿ   Bracard, S ⁿ   Vercelletto, M ⁿ   Calvier Auffray, E ⁿ   Robert, P ⁿ   Chanalet, S ⁿ   Hugon, J ⁿ   Pancrazi, M P ⁿ   Reizine, D ⁿ   Gil, R ⁿ   Vandermarcq, P ⁿ   Novella, J L ⁿ   Pierot, L ⁿ   Belliard, S ⁿ   Carsin, M ⁿ   Martinaud, O ⁿ   Gerardin, E ⁿ   Laurent, B ⁿ   Barral, F G ⁿ   Sellal, F ⁿ   Puel, M ⁿ   Dumas, H ⁿ   Mondon, K ⁿ   Cottier, J P ⁿ   more..

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d HÔPITAL NEUROLOGIQUE   (France)

^e MONTPELLIER UNIVERSITY HOSPITAL   (France)

^f Toulouse University   (France)

^g CLINIQUE PASTEUR   (France)

^h HÔPITAL DU BOCAGE   (France)

ⁱ UNIV LILLE   (France)

^j LILLE UNIVERSITY HOSPITAL   (France)

^k TIMONE HOSPITAL   (France)

^l UNIVERSITÉ DE BORDEAUX   (France)

^m Eisai   (France)

ⁿ Eisai SAS ^*  (France)

more..

Author keywords

Alzheimer's disease; Amnestic MCI; Biomarker; Donepezil; Hippocampus; Mild cognitive impairment; MRI; Prodromal Alzheimer's disease; Randomized controlled trial; Rate of atrophy; Therapy; Volumetric imaging; Whole brain analysis

Indexed keywords

DONEPEZIL; PLACEBO; INDAN DERIVATIVE; NEUROPROTECTIVE AGENT; PIPERIDINE DERIVATIVE;

ABDOMINAL PAIN; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; COGNITIVE DEFECT; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEADACHE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE SPASM; NAUSEA; NIGHTMARE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRODROMAL SYMPTOM; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; VERTIGO; ATROPHY; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECTS; FRANCE; MULTICENTER STUDY; ORGAN SIZE; PATHOLOGY; TREATMENT OUTCOME;

AGED; ALZHEIMER DISEASE; ATROPHY; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FRANCE; HIPPOCAMPUS; HUMANS; INDANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPROTECTIVE AGENTS; ORGAN SIZE; PIPERIDINES; PRODROMAL SYMPTOMS; TREATMENT OUTCOME;

EID: 84942197370     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.10.003     Document Type: Article

References (22)

1. B. Dubois, H.H. Feldman, C. Jacova, J.L. Cummings, S.T. Dekosky, P. Barberger-Gateau, and et al. Revising the definition of Alzheimer's disease: a new lexicon Lancet Neurol 9 2010 1118 1127
2. B. Dubois, H.H. Feldman, C. Jacova, S.T. Dekosky, P. Barberger-Gateau, J. Cummings, and et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 6 2007 734 746
3. M. Sarazin, C. Berr, J. De Rotrou, C. Fabrigoule, F. Pasquier, S. Legrain, and et al. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study Neurology 69 2007 1859 1867
4. M. Sarazin, V. Chauvire, E. Gerardin, O. Colliot, S. Kinkingnéhun, L.C. de Souza, and et al. The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study J Alzheimers Dis 22 2010 285 294
5. M. Wagner, S. Wolf, F.M. Reischies, M. Daerr, S. Wolfsgruber, F. Jessen, and et al. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease Neurology 78 2012 379 386
6. C.R. Jack Jr., M.M. Shiung, J.L. Gunter, P.C. O'Brien, S.D. Weigand, D.S. Knopman, and et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD Neurology 62 2004 591 600
7. N.E. Carlson, M.M. Moore, A. Dame, D. Howieson, L.C. Silbert, J.F. Quinn, and et al. Trajectories of brain loss in aging and the development of cognitive impairment Neurology 70 2008 828 833
8. O.T. Carmichael, O. Lopez, J.T. Becker, and L. Kuller Trajectories of brain loss in aging and the development of cognitive impairment Neurology 72 2009 771 772 author reply
9. J. Birks, and R.J. Harvey Donepezil for dementia due to Alzheimer's disease Cochrane Database Syst Rev 2006 CD001190
10. K.R. Krishnan, H.C. Charles, P.M. Doraiswamy, J. Mintzer, R. Weisler, X. Yu, and et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease Am J Psychiatry 160 2003 2003 2011
11. M. Hashimoto, H. Kazui, K. Matsumoto, Y. Nakano, M. Yasuda, and E. Mori Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Am J Psychiatry 162 2005 676 682
12. J. Birks, and L. Flicker Donepezil for mild cognitive impairment Cochrane Database Syst Rev 3 2006 CD006104
13. R.S. Doody, S.H. Ferris, S. Salloway, Y. Sun, R. Goldman, W.E. Watkins, and et al. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial Neurology 72 2009 1555 1561
14. C.R. Jack Jr., R.C. Petersen, M. Grundman, S. Jin, A. Gamst, C.P. Ward, and et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI Neurobiol Aging 29 2008 1285 1295
15. N. Schuff, J. Suhy, R. Goldman, Y. Xu, Y. Sun, D. Truran-Sacrey, and et al. An MRI substudy of a donepezil clinical trial in mild cognitive impairment Neurobiol Aging 32 2011 2318 e31 2341.e31
16. B. Dubois, G. Picard, and M. Sarazin Early detection of Alzheimer's disease: new diagnostic criteria Dialogues Clin Neurosci 11 2009 135 139
17. M. Chupin, A. Hammers, R.S. Liu, O. Colliot, J. Burdett, E. Bardinet, and et al. Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: method and validation Neuroimage 46 2009 749 761
18. S.M. Smith, A. Rao, N. De Stefano, M. Jenkinson, J.M. Schott, P.M. Matthews, and et al. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX Neuroimage 36 2007 1200 1206
19. P.A. Freeborough, and N.C. Fox The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI IEEE Trans Med Imaging 16 1997 623 629
20. Z. Xue, D. Shen, and C. Davatzikos CLASSIC: consistent longitudinal alignment and segmentation for serial image computing Neuroimage 30 2006 388 399
21. C.R. Jack Jr., M. Slomkowski, S. Gracon, T.M. Hoover, J.P. Felmlee, K. Stewart, and et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD Neurology 60 2003 253 260
22. A. Solomon, F. Mangialasche, E. Richard, S. Andrieu, D.A. Bennett, M. Breteler, and et al. Advances in the prevention of Alzheimer's disease and dementia J Intern Med 275 2014 229 250